Thursday, November 28, 2024 11:09:38 AM
That Theory is Wrong! This is a company trying that is TRYING TO CURE CANCER! Their lead product was submitted for approval in December of 2023 and hopefully should be approved my MHRA any day now. The probability you are employed by one of the 7 Market Makers that NWBO filed a lawsuit against in December of 2022 (almost 2 years ago) is extremely high and the MTD will probably be denied any day now.
Some here would disagree with your statement that we are only here to make money. This is a pre revenue biotech stock. Until Approval, which is a binary event, it’s pretty difficult to make money as the company is preparing to sell their product and they are prohibited to sell their product.
The investors are not in fantasy land read the Journal Article endorsed by 73 coauthors. As I stated above, we all believe the product will be approved and DCVax-L will ultimately be the a platform and an integral part of treating cancer. Ultimately, this will end the use of chemotherapy. So you can also be a paid basher of one of those products. Your existence is disgusting.
Some here would disagree with your statement that we are only here to make money. This is a pre revenue biotech stock. Until Approval, which is a binary event, it’s pretty difficult to make money as the company is preparing to sell their product and they are prohibited to sell their product.
The investors are not in fantasy land read the Journal Article endorsed by 73 coauthors. As I stated above, we all believe the product will be approved and DCVax-L will ultimately be the a platform and an integral part of treating cancer. Ultimately, this will end the use of chemotherapy. So you can also be a paid basher of one of those products. Your existence is disgusting.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
